PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

UIN 901341

Drugs: Safety

answeredUnited Kingdom· UK Parliament· EN

Introduced

14 November 2024

Last action

20 November 2024 · Answer

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

20 November 2024

Summary

What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 November 2024

    Written question

    What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.

    Source: Commons

  2. 20 November 2024

    Answer

    The Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.

    Source: Written answer

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.